Tower Research Capital LLC (TRC) - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 16 filers reported holding BELLEROPHON THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$0
-100.0%
101
-85.6%
0.00%
Q3 2016$1,0000.0%700
-4.5%
0.00%
Q2 2016$1,000
-50.0%
7330.0%0.00%
Q1 2016$2,000
+100.0%
733
+266.5%
0.00%
Q3 2015$1,000
-66.7%
200
-41.5%
0.00%
Q2 2015$3,0000.0%342
+3.0%
0.00%
Q1 2015$3,0003320.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
KLINSKY STEVEN B 4,859,885$44,614,00020.33%
Senator Investment Group LP 448,679$4,119,0000.04%
HIGHLAND CAPITAL MANAGEMENT LP 162,177$1,489,0000.03%
Baker Brothers Advisors 350,000$3,213,0000.03%
Alyeska Investment Group, L.P. 94,131$864,0000.01%
SABBY MANAGEMENT, LLC 30,000$275,0000.01%
FMR LLC 1,302,070$11,953,0000.00%
MILLENNIUM MANAGEMENT LLC 15,427$142,0000.00%
BlackRock Investment Management, LLC 846$8,0000.00%
GOLDMAN SACHS GROUP INC 17,290$159,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders